3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
45
Prostatic Neoplasms
41
Brain Neoplasms
27
Lung Neoplasms
19
Glioblastoma
17
Glioma
16
Neoplasms
13
Neoplasm Metastasis
13
Carcinoma, Non-Small-Cell Lung
13
Head and Neck Neoplasms
10
Pancreatic Neoplasms
8
Central Nervous System Neoplasms
8
Uterine Cervical Neoplasms
7
Lymphoma
7
Carcinoma, Hepatocellular
7
Rectal Neoplasms
6
Oligodendroglioma
6
Gliosarcoma
6
Carcinoma, Squamous Cell
6
Astrocytoma
6
Squamous Cell Carcinoma of Head and Neck
5
Esophageal Neoplasms
5
Ependymoma
5
Colorectal Neoplasms
5
Carcinoma, Renal Cell
5
Carcinoma, Intraductal, Noninfiltrating
5
Sarcoma
4
Meningioma
4
Colonic Neoplasms
4
Breast Neoplasms, Male
4
Interventions
regorafenib
1
X-Rays
1
Transurethral Resection of Bladder
1
Surgical Procedures, Operative
1
Standard of Care
1
Radiotherapy
1
Oxaliplatin
1
Magnetic Resonance Spectroscopy
1
Fluorouracil
1
Exercise
1
Endoscopy
1
Chemoradiotherapy
1
Cell-Free Nucleic Acids
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Pathologic Complete Response
×
Magnetic Resonance Spectroscopy
×
Clear all
NCT01956513
2013-10-08
ADC
Centre Jean Perrin
Phase NA
Withdrawn